\n

Glymin^??XR

\n

Metformin

\nDescription \nMetformin is a biguanide antihyperglycemic agent, which improves glucose tolerance in patients with type 2 diabetes, lowering both basal and postprandial plasma glucose. Its pharmacological mechanisms of action are different from other classes of oral antihyperglycemic agents. Metformin decreases hepatic glucose production, decreases intestinal absorption of glucose, and improves insulin sensitivity by increasing peripheral glucose uptake and utilization. Unlike sulfonylurea, metformin does not produce hypoglycemia in either patient with type 2 diabetes or normal subjects and does not cause hyperinsulinemia. \nsulfonylurea hypoglycemic drugs. \n \nIndications \nGlymin^??XR (metformin hydrochloride extended-release tablets) are oral antihyperglycemic drug that is indicated in the following cases: \n \nNon-insulin dependent diabetes mellitus (NIDDM) or type 2 diabetes, as an adjunct to diet & exercise to improve glycemic control \nInsulin dependent diabetes mellitus (IDDM), as adjuvant therapy in combination with insulin \nMay be used concomitantly with a sulfonylurea or insulin to improve glycemic control in adults \n \nSupply \nGlymin^??XR 500mg Tablet: Box containing 10 x 5?s tablets in blister pack \n \n